Ixabiso elihle yi-99% ye-Orlistat/Orlistat powder yodidi lwamayeza CAS 96829-58-2

Intshayelelo:
I-Orlistat liyeza elenzelwe ukunyanga ukutyeba kakhulu. Umsebenzi walo oyintloko kukuthintela ukufunxwa kwamafutha kukutya kwabantu ngokusebenza njengomthinteli we-lipase, ngaloo ndlela kunciphisa ukutya okune-caloric. Lenzelwe ukusetyenziswa kunye nokutya okune-calories ezincitshisiweyo okujongwa ngumboneleli wezempilo.

I-Orlistat sisithako esipheleleyo se-lipstatin, isithinteli sendalo esinamandla se-pancreatic lipases esahlulwe kwi-bacteria iStreptomyces toxytricini. Nangona kunjalo, ngenxa yobulula bayo kunye nozinzo, i-orlistat yakhethwa endaweni ye-lipstatin ukuze iphuhliswe njengeyeza lokulwa nokutyeba.

Ukusebenza kwe-orlistat ekukhuthazeni ukwehla kobunzima kucacile kodwa kuncinci. Idatha eqokelelweyo evela kuvavanyo lweklinikhi ibonisa ukuba abantu abanikwe i-orlistat ukongeza kutshintsho lwendlela yokuphila, njengokutya kunye nokuzilolonga, balahlekelwa malunga neekhilogram ezi-2–3 (4.4–6.6 lb) ngaphezulu kwabo bangathathi eli yeza unyaka wonke. I-Orlistat ikwanciphisa uxinzelelo lwegazi ngokuthobeka kwaye ibonakala ngathi ithintela ukuqala kwesifo seswekile sohlobo lwesibini, nokuba kukwehla kobunzima ngokwaso okanye kwezinye iziphumo. Kwilingo elikhulu elilawulwa ngokungacwangciswanga, i-orlistat ifunyenwe inciphisa ukwanda kwesifo seswekile phantse ngama-40% kubantu abatyebe kakhulu.

Izicelo:
I-Orlistat isetyenziswa kunye nokutya okuneekhalori eziphantsi ukukunceda unciphise umzimba kwaye ugcine ubunzima bakho emva kokunciphisa umzimba. I-Orlistat ikudidi lwamayeza abizwa ngokuba yi-lipase inhibitors. Isebenza emathunjini akho, apho ithintela amanye amafutha owatyayo ukuba angafunxwa kwaye acolwe. La mafutha angacolwanga emva koko asuswa kwiintshukumo zakho zamathumbu.

Ukupakisha:
25kg/ibhokisi